Skip to content
October 7, 2022
In the News
Seeking Alpha: Oramed oral COVID vaccine shows promise in phase 1 trial
Oramed oral COVID vaccine shows promise in phase 1 trial | Seeking Alpha
Prev
Previous
Fierce Biotech: Oramed phase 2 insulin drug data ‘paint an exciting picture’ in rocky NASH landscape
Next
Seeking Alpha: Oramed inks contract with Medicox to distribute oral insulin in South Korea
Next
You may also be interested
CEO Nadav Kidron on the TD Ameritrade Network
April 7, 2021
In the News
Insulin Pill for Diabetes Inches Closer to Reality
April 15, 2013
In the News
Israel21c: Israeli oral Covid vaccine to be developed in Mexico
November 23, 2021
In the News
Join our mailing list
Email
SUBSCRIBE
+1-844-9-ORAMED
office@oramed.com
Linkedin-in
Facebook-f
Twitter
Youtube
Home
About
Technology
Pipeline
Video Library
Contact us
NEWS
Press Releases
In the News
Scientific Articles and Abstracts
Events & Presentations
INVESTORS
Corporate presentation
Investor Relations
SEC filings
Investor FAQ
Governance documents
Annual shareholder meeting
Investor tools
Skip to content
Open toolbar
Accessibility Tools
Accessibility Tools
Increase Text
Increase Text
Decrease Text
Decrease Text
Grayscale
Grayscale
High Contrast
High Contrast
Negative Contrast
Negative Contrast
Light Background
Light Background
Links Underline
Links Underline
Readable Font
Readable Font
Reset
Reset
